CTVA
Overvalued by 30.9% based on the discounted cash flow analysis.
Market cap | $38.23 Billion |
---|---|
Enterprise Value | $37.98 Billion |
Dividend Yield | $0.6271 (1.15%) |
Earnings per Share | $1.03 |
Beta | 0.0 |
Outstanding Shares | 698,880,420 |
Avg 30 Day Volume | 2,654,024 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.01 |
---|---|
PEG | 14.45 |
Price to Sales | 2.29 |
Price to Book Ratio | 1.57 |
Enterprise Value to Revenue | 2.2 |
Enterprise Value to EBIT | 17.91 |
Enterprise Value to Net Income | 51 |
Total Debt to Enterprise | 0.07 |
Debt to Equity | 0.1 |
No data
No data
Corteva Agriscience is a publicly traded, global pure-play agriculture company that provides farmers around the world with the most complete portfolio in the industry - including a balanced and diverse mix of seed, crop protection and di...